Literature DB >> 21129015

Tumor size as a prognostic factor in resected small hepatocellular carcinoma: a controversy revisited.

Yao-Li Chen1, Chih-Jan Ko, Su-Yu Chien, Li-Sheng Chen, Mei-Ling Chen, Chin-Wen Chi, Hung-Wen Lai.   

Abstract

BACKGROUND AND AIM: The widespread use of screening programs has resulted in an increase in detection of small hepatocellular carcinoma (HCC). Surgical resection generally leads to favorable outcomes in this group of patients; however, the prognostic significance of tumor size and the optimal cutoff point in resected specimens of small HCC have not been well defined. The aim of current study is to evaluate the prognostic significance of tumor size in small resected HCC.
METHODS: Patients who underwent surgical resection for small HCC at the Changhua Christian Hospital during January 2001 to June 2007 were enrolled. Small HCC was defined as a single HCC nodule with maximum diameter ≤ 5 cm. Cox regression hazard ratios for cancer-specific death were calculated to survey the prognostic significance of tumor size. We then determined the optimal cut-point for tumor size that could be used to stratify patients into 5-year disease-free survival (DFS) and cancer-specific survival (CSS) groups.
RESULTS: A total of 140 patients who underwent resection of small HCC were enrolled. The mean tumor size was 2.9 cm (range 0.9-5.0) and the mean follow-up period was 43.4 months. The 5-year DFS and CSS rates were 46.6% and 81.6%, respectively. Cox regression analysis revealed that tumor size (hazard ratio = 2.973, 95% confidence interval: 1.073-8.239, P = 0.036) was an independent prognostic factor. Our analysis showed that a tumor size of 3 cm was the cut-point that could dichotomize patients into statistically different 5-year DFS and CSS risk groups.
CONCLUSIONS: Tumor size is an independent prognostic factor in resected small HCC and the prognostic significance of tumor size may vary according to different cut-off points.
© 2011 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21129015     DOI: 10.1111/j.1440-1746.2010.06595.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  13 in total

1.  Proposal of new classification for postoperative patients with hepatocellular carcinoma based on tumor growth characteristics.

Authors:  Cui-Hong Zhu; Xiao-Hui Liu; Rui Cao; Xiong-Zhi Wu
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

2.  Upregulation of colonic and hepatic tumor overexpressed gene is significantly associated with the unfavorable prognosis marker of human hepatocellular carcinoma.

Authors:  Jun-Xiong Yu; Qian Chen; Ya-Qun Yu; Shu-Qun Li; Jian-Fei Song
Journal:  Am J Cancer Res       Date:  2016-02-15       Impact factor: 6.166

3.  Evaluation of prognostic factors on recurrence after curative resections for hepatocellular carcinoma.

Authors:  Jae Hyun Han; Dong Goo Kim; Gun Hyung Na; Eun Young Kim; Soo Ho Lee; Tae Ho Hong; Young Kyoung You
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

4.  The tumor-to-breast volume ratio (TBR) predicts cancer-specific survival in breast cancer patients who underwent modified radical mastectomy.

Authors:  Jiahuai Wen; Feng Ye; Xiaojia Huang; Shuaijie Li; Lu Yang; Xiangsheng Xiao; Xiaoming Xie
Journal:  Tumour Biol       Date:  2015-12-17

5.  A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.

Authors:  Pengpeng Zhu; Junfei Jin; Yan Liao; Jun Li; Xue-Zhong Yu; Weijia Liao; Songqing He
Journal:  Oncotarget       Date:  2015-12-01

6.  Factors determining long-term outcomes of hepatocellular carcinoma within the Milan criteria: liver transplantation versus locoregional therapy: A retrospective cohort study.

Authors:  Jung Hee Kim; Dong Hyun Sinn; Geum-Youn Gwak; Gyu-Seong Choi; Jong Man Kim; Choon Hyuck David Kwon; Jae-Won Joh; Ki Yeon Kim; Kyunga Kim; Yong-Han Paik; Moon Seok Choi; Joon Hyeok Lee; Kwang Cheol Koh; Seung Woon Paik
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

7.  The preoperative alkaline phosphatase-to-platelet ratio index is an independent prognostic factor for hepatocellular carcinoma after hepatic resection.

Authors:  Ya-Qun Yu; Jun Li; Yan Liao; Qian Chen; Wei-Jia Liao; Jian Huang
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.889

8.  Elevated preoperative aspartate aminotransferase to lymphocyte ratio index as an independent prognostic factor for patients with hepatocellular carcinoma after hepatic resection.

Authors:  Junfei Jin; Pengpeng Zhu; Yan Liao; Jun Li; Weijia Liao; Songqing He
Journal:  Oncotarget       Date:  2015-08-07

9.  Factors influencing hepatocellular carcinoma prognosis after hepatectomy: a single-center experience.

Authors:  Sung Keun Park; Young Kul Jung; Dong Hae Chung; Keon Kuk Kim; Yeon Ho Park; Jung Nam Lee; Oh Sang Kwon; Yun Soo Kim; Duck Joo Choi; Ju Hyun Kim
Journal:  Korean J Intern Med       Date:  2013-07-01       Impact factor: 2.884

10.  Combined analysis of serum alpha-fetoprotein and MAGE-A3-specific cytotoxic T lymphocytes in peripheral blood for diagnosis of hepatocellular carcinoma.

Authors:  Zhuqingqing Cui; Xin Yu; Limin Guo; Yuhua Wei; Shengmin Zheng; Wenxia Li; Pengcheng Chen; Jiye Zhu; Jirun Peng
Journal:  Dis Markers       Date:  2013       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.